Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01667952 · ClinicalTrials.gov registry record
Prospective Ascertainment for Late Effects Among Survivors of Cancer, Tumor, or a Related Illness
A clinical trial of Pediatric or Young Adult Cancer Survivors, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 1,068
- Enrollment target
- 1
- Study location
NCT01667952 is a study of Pediatric or Young Adult Cancer Survivors that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,068 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01667952, a study of Pediatric or Young Adult Cancer Survivors, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 1,068 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to establish a registry of survivors of cancer, tumor, or a related illness.
Conditions Studied
Interventions
- OTHER Blood sample
- GENETIC Family History Questionnaire (FHQ)
- GENETIC Salvia sample
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,068 participants |
| Start Date | 2012-08 |
| Est. Completion | 2025-03-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01667952
The ClinicalTrials.gov registry entry for NCT01667952 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,068 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pediatric or Young Adult Cancer Survivors appearing as the primary indexed condition, and to 3 interventions - of which Blood sample is the first listed.
NCT01667952 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT01667952 about?
NCT01667952 is a clinical study titled "Prospective Ascertainment for Late Effects Among Survivors of Cancer, Tumor, or a Related Illness". The purpose of this study is to establish a registry of survivors of cancer, tumor, or a related illness.
What is the current status of trial NCT01667952?
This trial is currently completed. The enrollment target is 1,068 participants. The study started on 2012-08. Estimated completion is 2025-03-06.
What conditions does trial NCT01667952 study?
This clinical trial studies the following conditions: Pediatric or Young Adult Cancer Survivors.
What interventions are being tested in trial NCT01667952?
The interventions under investigation include: Blood sample (OTHER), Family History Questionnaire (FHQ) (GENETIC), Salvia sample (GENETIC).
Who is sponsoring clinical trial NCT01667952?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01667952 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.